Company
Bolt Biotherapeutics Inc (NASDAQ: BOLT) Shares Are Heading Higher
In the last trading session, 0.23 million shares of the Bolt Biotherapeutics Inc (NASDAQ:BOLT) were traded, and its beta was 0.94. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.